HealthEquity Total Long-Term Assets 2014-2024 | HQY

HealthEquity total long-term assets from 2014 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • HealthEquity total long-term assets for the quarter ending July 31, 2024 were $3.019B, a 14.18% increase year-over-year.
  • HealthEquity total long-term assets for 2024 were $2.606B, a 3.68% decline from 2023.
  • HealthEquity total long-term assets for 2023 were $2.706B, a 1.81% decline from 2022.
  • HealthEquity total long-term assets for 2022 were $2.756B, a 22.47% increase from 2021.
HealthEquity Annual Total Long-Term Assets
(Millions of US $)
2024 $2,606
2023 $2,706
2022 $2,756
2021 $2,250
2020 $2,268
2019 $115
2018 $104
2017 $78
2016 $77
2015 $34
2014 $31
2013 $31
HealthEquity Quarterly Total Long-Term Assets
(Millions of US $)
2024-07-31 $3,019
2024-04-30 $2,842
2024-01-31 $2,606
2023-10-31 $2,619
2023-07-31 $2,644
2023-04-30 $2,677
2023-01-31 $2,706
2022-10-31 $2,733
2022-07-31 $2,765
2022-04-30 $2,786
2022-01-31 $2,756
2021-10-31 $2,335
2021-07-31 $2,288
2021-04-30 $2,297
2021-01-31 $2,250
2020-10-31 $2,261
2020-07-31 $2,281
2020-04-30 $2,279
2020-01-31 $2,268
2019-10-31 $2,290
2019-07-31 $245
2019-04-30 $232
2019-01-31 $115
2018-10-31 $114
2018-07-31 $115
2018-04-30 $114
2018-01-31 $104
2017-10-31 $103
2017-07-31 $91
2017-04-30 $84
2017-01-31 $78
2016-10-31 $78
2016-07-31 $77
2016-04-30 $77
2016-01-31 $77
2015-10-31 $71
2015-07-31 $35
2015-04-30 $35
2015-01-31 $34
2014-10-31 $34
2014-07-31 $35
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-01-31 $33
Sector Industry Market Cap Revenue
Medical Medical Services $6.771B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $125.093B 15.25
Cencora (COR) United States $45.021B 17.20
ICON (ICLR) Ireland $24.951B 22.42
DiDi Global (DIDIY) China $18.956B 0.00
Avantor (AVTR) United States $18.396B 27.90
Natera (NTRA) United States $15.720B 0.00
Revvity (RVTY) United States $15.367B 26.91
Viatris (VTRS) United States $14.203B 4.33
CochLear (CHEOY) Australia $12.751B 0.00
Solventum (SOLV) United States $12.458B 0.00
Medpace Holdings (MEDP) United States $11.201B 33.99
Charles River Laboratories (CRL) United States $10.641B 20.11
Sonic Healthcare (SKHHY) Australia $8.811B 0.00
Doximity (DOCS) United States $7.438B 47.13
Bausch + Lomb (BLCO) Canada $7.041B 30.30
PACS (PACS) United States $6.218B 0.00
Organon (OGN) United States $5.142B 5.23
Life Times (LTH) United States $4.879B 40.78
Sotera Health (SHC) United States $4.741B 23.91
Surgery Partners (SGRY) United States $4.088B 45.30
Concentras Parent (CON) United States $2.955B 0.00
GoodRx Holdings (GDRX) United States $2.789B 105.00
BrightSpring Health Services (BTSG) United States $2.550B 0.00
Ardent Health Partners (ARDT) United States $2.438B 0.00
Progyny (PGNY) United States $2.206B 38.79
Alignment Healthcare (ALHC) United States $2.177B 0.00
Premier (PINC) United States $2.052B 9.23
Ryman Healthcare (RYHTY) New Zealand $1.921B 0.00
AMN Healthcare Services Inc (AMN) United States $1.778B 8.93
Agilon Health (AGL) United States $1.642B 0.00
Teladoc Health (TDOC) United States $1.556B 0.00
CareDx (CDNA) United States $1.543B 0.00
Establishment Labs Holdings (ESTA) $1.183B 0.00
GeneDx Holdings (WGS) United States $1.044B 0.00
QDM (QDMI) Hong Kong, SAR China $0.933B 24.43
Pediatrix Medical (MD) United States $0.933B 10.15
Embecta (EMBC) United States $0.895B 5.97
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.551B 0.00
Sharecare (SHCR) United States $0.527B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Enhabit (EHAB) United States $0.410B 35.48
Sonida Senior Living (SNDA) United States $0.370B 0.00
DocGo (DCGO) United States $0.361B 13.58
Sera Prognostics (SERA) United States $0.261B 0.00
Biodesix (BDSX) United States $0.253B 0.00
LifeMD (LFMD) United States $0.226B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
ModivCare (MODV) United States $0.192B 6.11
Beauty Health (SKIN) United States $0.187B 0.00
MultiPlan (MPLN) United States $0.152B 0.00
Nutex Health (NUTX) United States $0.126B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.083B 0.00
So-Young (SY) China $0.081B 19.72
Singular Genomics Systems (OMIC) United States $0.042B 0.00
NeueHealth (NEUE) United States $0.042B 1.66
Co-Diagnostics (CODX) United States $0.041B 0.00
OncoCyte (OCX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.026B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.021B 0.00
TRxADE HEALTH (MEDS) United States $0.010B 0.00
XWELL (XWEL) United States $0.010B 0.00
KindlyMD (KDLY) $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00